Characterization of pneumococcal meningitis before and after introduction of 13-valent pneumococcal conjugate vaccine in Niger, 2010–2018 - Ousmane, Sani; Kobayashi, Miwako; Seidou, Issaka; Issaka, Bassira; Sharpley, Sable; Farrar, Jennifer L.; Whitney, Cynthia G.; Ouattara, Mahamoudou (Vaccine, 2020)
Keywords: Adolescent; Adult; Adults; African meningitis belt; Aged; Allergy and Immunology; Cerebrospinal fluid; Child; Child, Preschool; Children; Conjugates; Data collection; Deoxyribonucleic acid; Disease; Disease control; DNA; Epidemics; Etiology; Humans; Immunization; Impact; Infant; Medical laboratories; Meningitis; Meningitis, Pneumococcal - epidemiology; Meningitis, Pneumococcal - prevention & control; monitoring; Niger; Niger - epidemiology; Pathogens; Pneumococcal conjugate vaccine; Pneumococcal Infections - epidemiology; Pneumococcal Infections - prevention & control; Pneumococcal meningitis; Pneumococcal Vaccines; Polymerase chain reaction; quantitative polymerase chain reaction; Real time; Schedules; Serogroup; Serotypes; Serotyping; Streptococcus infections; Streptococcus pneumoniae; Streptococcus pneumoniae - immunology; Surveillance; Vaccination; Vaccines; Vaccines, Conjugate; Niger; United States--US; Impact; Pneumococcal conjugate vaccine; African meningitis belt; Pneumococcal meningitis